162 related articles for article (PubMed ID: 32110756)
1. Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism-the Tromsø study.
Børvik T; Evensen LH; Morelli VM; Melbye H; Brækkan SK; Hansen JB
Res Pract Thromb Haemost; 2020 Feb; 4(2):255-262. PubMed ID: 32110756
[TBL] [Abstract][Full Text] [Related]
2. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
[TBL] [Abstract][Full Text] [Related]
3. COPD and risk of venous thromboembolism and mortality in a general population.
Børvik T; Brækkan SK; Enga K; Schirmer H; Brodin EE; Melbye H; Hansen JB
Eur Respir J; 2016 Feb; 47(2):473-81. PubMed ID: 26585434
[TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromsø Study.
Børvik T; Brækkan SK; Evensen LH; Brodin EE; Morelli VM; Melbye H; Hansen JB
Thromb Haemost; 2020 Mar; 120(3):477-483. PubMed ID: 31887782
[TBL] [Abstract][Full Text] [Related]
5. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study.
Tøndel BG; Sejrup JK; Morelli VM; Løchen ML; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Brækkan SK
Res Pract Thromb Haemost; 2024 Mar; 8(3):102392. PubMed ID: 38665865
[TBL] [Abstract][Full Text] [Related]
6. Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.
Småbrekke B; Rinde LB; Hald EM; Njølstad I; Mathiesen EB; Johnsen SH; Hansen JB; Braekkan SK; Lijfering WM
J Thromb Haemost; 2017 Dec; 15(12):2344-2351. PubMed ID: 28981216
[TBL] [Abstract][Full Text] [Related]
7. Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.
Rinde LB; Lind C; Småbrekke B; Njølstad I; Mathiesen EB; Wilsgaard T; Løchen ML; Hald EM; Vik A; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Jun; 14(6):1183-91. PubMed ID: 27061154
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.
Hald EM; Enga KF; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Am Heart Assoc; 2014 Jan; 3(1):e000483. PubMed ID: 24385452
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: The Tromsø study.
Hald EM; Løchen ML; Mathiesen EB; Wilsgaard T; Njølstad I; Brækkan SK; Hansen JB
Res Pract Thromb Haemost; 2020 Aug; 4(6):1004-1012. PubMed ID: 32864551
[TBL] [Abstract][Full Text] [Related]
10. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study.
Sejrup JK; Tøndel BG; Morelli VM; Løchen ML; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Braekkan SK
J Thromb Haemost; 2022 Oct; 20(10):2342-2349. PubMed ID: 35815348
[TBL] [Abstract][Full Text] [Related]
11. Hand grip strength and risk of incident venous thromboembolism: The Tromsø study.
Leknessund OGR; Morelli VM; Strand BH; Hansen JB; Brækkan SK
Res Pract Thromb Haemost; 2022 Oct; 6(7):e12833. PubMed ID: 36349264
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study.
Enga KF; Rye-Holmboe I; Hald EM; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Braekkan SK; Hansen JB
J Thromb Haemost; 2015 Jan; 13(1):10-6. PubMed ID: 25330989
[TBL] [Abstract][Full Text] [Related]
13. White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism--the Tromsø study.
Blix K; Jensvoll H; Brækkan SK; Hansen JB
PLoS One; 2013; 8(9):e73447. PubMed ID: 24023876
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism and subsequent permanent work-related disability.
Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
[TBL] [Abstract][Full Text] [Related]
15. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.
Frischmuth T; Tøndel BG; Brækkan SK; Hansen JB; Morelli VM
Thromb Haemost; 2024 Mar; 124(3):239-249. PubMed ID: 37549694
[TBL] [Abstract][Full Text] [Related]
17. Repeated assessments of physical activity and risk of incident venous thromboembolism.
Evensen LH; Isaksen T; Hindberg K; Braekkan SK; Hansen JB
J Thromb Haemost; 2018 Nov; 16(11):2208-2217. PubMed ID: 30191665
[TBL] [Abstract][Full Text] [Related]
18. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the Tromsø study.
Lerstad G; Brodin EE; Enga KF; Jorde R; Schirmer H; Njølstad I; Svartberg J; Braekkan SK; Hansen JB
J Thromb Haemost; 2014; 12(3):313-9. PubMed ID: 24382156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
